Quercetin (Que) is an abundant flavonoid in the human diet and high-concentration food supplement with reported proand anti-carcinogenic activities. Topoisomerase II (TopoII) inhibition and subsequent DNA damage induction by Que was implicated in the mixed lineage leukemia gene (MLL) rearrangements that can induce infant and adult leukemias. This notion raised concerns regarding possible genotoxicities of Que in hematopoietic stem and progenitor cells (HSPCs). However, molecular targets mediating Que effects on DNA repair relevant to MLL translocations have not been defined. In this study we describe novel and potentially genotoxic Que activities in suppressing non-homologous end joining and homologous recombination pathways downstream of MLL cleavage. Using pharmacological dissection of DNA-PK, ATM and PI3K signalling we defined PI3K inhibition by Que with a concomitant decrease in the abundance of key DNA repair genes to be responsible for DNA repair inhibition. Evidence for the downstream TopoII-independent mutagenic potential of Que was obtained by documenting further increased frequencies of MLL rearrangements in human HSPCs concomitantly treated with Etoposide and Que versus single treatments. Importantly, by engaging a tissue engineered placental barrier, we have established the extent of Que transplacental transfer and hence provided the evidence for Que reaching fetal HSPCs. Thus, Que exhibits genotoxic effects in human HSPCs via different mechanisms when applied continuously and at high concentrations. In light of the demonstrated Que transfer to the fetal compartment our findings are key to understanding the mechanisms underlying infant leukemia and provide molecular markers for the development of safety values.
chemical structure of Que that can alter the oxidative state of the cells 2 inhibit cellular enzymes involved in the regulation of DNA topology (TopoII), 3 signal transduction (e.g. PI3-kinase, protein kinase C, tyrosine kinase receptors), 4 protein degradation 5 and more. 1 In particular, inhibition of TopoII can generate persistent DNA double strand breaks (DSBs) that trigger cell death as well as chromosomal aberrations in some of the surviving cells. Whereas the strong cytotoxic effect of the synthetic TopoII poison Etoposide (Eto) towards many types of malignant cells accounts for its use as frontline chemotherapy, its administration also significantly elevates the incidence of secondary cancer. 6 Strikingly, most of the malignancies linked to the previous usage of TopoII inhibitor-based therapy are myeloid leukemia (t-AML) characterized by hallmark mixed lineage leukemia (MLL) gene rearrangements. Very similar MLL aberrations were also found in the majority of infant leukemia cases (80%) and thought to originate from DNA insults during fetal hematopoiesis in utero. 7 MLL locus abnormalities generate potent oncogenes sufficient to drive leukemogenesis. 6 Similarity in driver mutation type (MLL translocations) in both adult t-AML and the infant disease rationalized the hypothesis that inadvertent exposure of the fetus to the maternal diet rich in TopoII inhibitors (e.g. via habitual intake of high-concentration supplements) might instigate MLL locus rearrangements in the developing fetal hematopoietic cells. 8 A similar degree of MLL gene cleavage by synthetic TopoII inhibitors (Eto) and natural bioflavonoids including Que were reported in vitro, [9] [10] [11] [12] although Eto caused formation of more persistent TopoII-DNA complexes that accounted for its higher cytotoxicity. 13, 14 Two case-control epidemiological studies aimed to investigate whether maternal diet that contained compounds classified as DNA damaging would increase the incidence of infant leukemia revealed significant association between MLL-positive leukemias and fetus exposure to genotoxins. 15, 16 However, given the rarity of the samples, complexity of human diet and responders bias it is difficult to firmly establish whether TopoII inhibition is the sole mechanism leading to MLL rearrangements. Moreover, in recent years, multiple TopoIIindependent pathways were implicated in leukemogenic rearrangements at the MLL locus. 17 These mechanisms include early apoptotic DNA fragmentation, 18, 19 as well as, transcription and replication machineries' stalling. 20 Despite the above evidences, the characteristics of Que maternal-to-fetal transport across the placental barrier as well as its effect on DNA repair pathways relevant to MLL rearrangements in hematopoietic cells have not yet been precisely defined. Therefore, the present study was designed to both quantify transfer of Que across placental cellular barrier (PB) 21 and to define more closely Que cellular targets with regard to MLL gene rearrangements. Our experiments have established that 10% of the Que amount at the maternal side reaches the fetal side in the tissue-engineered PB model without inducing damage to the barrier itself. Using DNA repair assays we found that Que is capable of blocking DNA repair pathways implicated in MLL abnormalities downstream of MLL cleavage. We implicated PI3K/Akt inhibition by Que as the mechanism responsible for DSB repair suppression. Furthermore, detailed fluorescent in situ hybridization analysis (FISH) of MLL locus integrity in human immature hematopoietic cells documented increased frequencies of MLL rearrangements provoked by combined Que and Eto exposure. Ultimately, we highlighted the genotoxic potential of widely consumed bioflavonoid in the context of maternal-fetal transfer with relevance for infant leukemia etiology.
Material and Methods

Cell culture and chemical treatment
Human umbilical vein endothelial cells (HUVEC) (Lonza) were cultured in ECGM with supplement-mix V R (PromoCell). Human trophoblast cells (HTR8) were cultured in RPMI 1640 medium (Gibco) supplemented with 10% FBS (BI, Israel). K562 leukemia cells were cultured in IMDM (Gibco) supplemented with FBS (10%) (BI, Israel). K562 and HTR8 cell lines were authenticated by short tandem repeat (STR) profiling using PowerPlex16 HS kit (Promega). All cell lines were tested negative for mycoplasma.
Lineage depletion and CD34 1 cell enrichment of cord blood samples were achieved by negative selection with the EasySep system according to the manufacturer's protocol (Stem Cell Technologies, Canada). CD341 cells were seeded in IMDM, 10% FBS supplemented with FLT3L (50 ng/ml), TPO (20 ng/ml), SCF (50 ng/ml) and IL-6 (10 ng/ml) at the density of 1 3 10 5 cells/ml and treated immediately or allowed to proliferate for 6 days and then exposed to the different treatments. Colony forming assay was performed in MethoCult TM H4434 Classic (Stem Cell Technologies, Canada). Colonies
What's new?
The bioflavinoid quercetin is known to induce rearrangements in the mixed-lineage leukemia (MLL) gene that serve an etiological role in infant leukemia. Quercetin genotoxicity in the fetal compartment, however, remains largely unexplored. Using a tissue-engineered placental barrier, the authors of the present study show that quercetin is capable of crossing into and accumulating on the fetal side of placental tissue. In addition, in human hematopoietic stem and progenitor cells, quercetin suppressed major DNA repair pathways and downregulated critical DNA repair factors. The evidence suggests that high concentrations of quercetin can damage the fetal genome through multiple pathways.
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were counted after 12 to 14 days of incubation. All cells were maintained in a humidified incubator at 378C and 5% CO 2 . The AMs were harvested from term placentas following the Tel Aviv Sourasky Medical Centre ethical approval and after the donors signed an informed consent. The AMs were denuded of their original cell layers by immersion in 1.7% NH 4 OH and mechanical scraping.
Quercetin, Genistein, Ascorbic acid (Asc) and Etoposide were purchased from Sigma. Que was dissolved in Dimethyl sulfoxide (DMSO) and kept as a 100 mM stock solution, protected from light at 2208C. Stabilization of Que in culture medium (CM) was obtained by adding Asc to the CM on the day of experiment.
In vitro placental barrier (PB) model
The PB was engineered from a co-culture of HUVEC and HTR8 on both sides of the denuded AM as described elsewhere. 21, 22 The flowing media in each compartment was CM and the flow rate was set to 8 ml/min to simulate capillary blood flow rate. The details of Que transfer quantification can be found in Supplemental Experimental Procedures.
cH2AX quantitation
For gH2AX analysis, cells were incubated with the compounds for the period indicated, washed and stained for cell surface markers using fluorochrome conjugated CD34 (BD Biosciences) and CD38 (BioLegend) monoclonal antibodies, fixed in formaldehyde (1.4%), permeabilized in ethanol (100%) followed by labeling with gH2AX antibody conjugated with AlexaFluor647 (BD Biosciences). DAPI (4 0 ,6-diamidino-2-phenylindole, 1 lg/ml) was added to visualize DNA content. Cells were analyzed with Gallios flow cytometer (Beckman Coulter).
Non-homologous end joining (NHEJ) and homologous recombination (HR) repair assays and genomic PCR 
Western blotting analysis
Primary antibody details can be found in Supporting Information Experimental Procedures.
Statistical analysis
The significance of differences among groups was calculated via Student's t-test and results were considered significantly different at p < 0.05. Each set of experiments was repeated at least three times on different dates. The data is presented as mean 6 standard error mean (SEM).
Results
Que can cross a cellular PB, induce DNA damage and MLL rearrangements in cycling HSPCs
Whilst Que transport via the human intestinal barrier and its concentration in plasma have been estimated, 25 the transplacental transport of this flavonoid on the other hand has remained largely unexplored. Therefore, we investigated Que transport using a model system for feto-maternal placental circulations by a two-compartment flow chamber with independently controlled flow circuits of culture medium (CM) simulating capillary blood flow. 21, 22 The PB was engineered via a co-culture of HTR8 and HUVEC cells on the maternal and fetal sides of the denuded AM, respectively (Fig. 1a) . Using this PB model system and mass spectrometry analysis (Supporting Information Figs. 1a and 1b) we recorded timedependent changes in Que concentration in maternal and fetal compartments with striking dependency on the barrier composition. In the case where the barrier consisted of the AM only, after 6 h the level of Que in the maternal compartment showed a relative decrease by 23%, while in the fetal compartment it reached 17% as compared to the initial concentration ( Fig. 1bi ). In contrast, adherence of trophoblast and endothelial layers on AM resulted in a more pronounced decrease of Que from the maternal side (31%), while on the fetal side a rise of only 10% was recorded (Fig. 1bii ). Thus, cell layers impeded the Que transfer rate in this PB model (Fig. 1biii ). These experimental measurements closely fit Fick's diffusion mathematical model (Supporting Information Figs. 1c and 1d). Also, we have found that in the presence of the cell layers, 16% of Que was absent from both compartments. Since we did not record any significant loss of Que with the AM only, absorption by the cell layers (HTR8 and HUVECs) that build the PB most likely underlies the net decrease of Que. Microscopic examination of HUVEC and HTR8 monolayers cultured on the AM exposed to Que during transfer studies did not reveal alteration in cell morphology, monolayer integrity, metabolic activity and cell cycle distribution (Supporting Information Fig. 2 ). Collectively, our transport study supports the notion that this flavonoid can reach and accumulate in fetal tissues in the context of human pregnancy. Numerous bioflavonoids, including Que, were shown to possess TopoII poison and inhibitory activities. 3, 9, 26 Having demonstrated that Que can pass the PB and therefore reach fetal hematopoietic cells-the target cells for infant leukemia initiation, we decided to use cord blood derived CD34
1
HSPCs to study the cytotoxic and genotoxic consequences of Que exposure. In order to assess whether Que induces a DNA damage response (DDR) in HSPCs we analyzed gH2AX signals, which are a sensitive indicator of different types of DNA damage, including DSBs. HSPCs contain both Hematopoietic Stem Cells as well as more mature progenitor/ precursor cells, the latter also express CD38 antigen. As these two fractions differ in their response to DNA damage, 27 we employed flow cytometry-based analysis to quantitate gH2AX positive cells in CD34
1 CD38 1 and CD34 1 CD38 2 subpopulations exposed to Que for 16 h. When tested on freshly isolated HPSCs, Que did not induce a detectable accumulation of DSBs even at a concentration of 50 lM in either of the subpopulations, compared to the DMSO-treated group (Fig. 1c, left) . On the contrary, Eto induced a 4.5-to 6-fold increase in the number of gH2AX positive cells at a concentration of 10 lM. Of note, both HSC and Progenitor subsets isolated from cord blood prevail in G0/G1 state and exit quiescence upon cytokine stimulation ex vivo. 28 To test whether Que induces DNA damage in cycling human HSPCs, the freshly isolated cells were stimulated with cytokines and allowed to proliferate for 6 days. Strikingly, Que treatment of cycling CD341 cells resulted in a dramatic rise of the percentage of gH2AX positive cells reaching the level of the Eto treated group (Fig. 1c, right) . Similarly, Que treatment of cycling fetal trophoblast cells (HTR8 cell line) resulted in a strong elevation in the proportion of gH2AX positive cells. Thus, Que induced a DDR preferentially in cycling cells but not in quiescent HSPCs. In some cells, the DDR machinery prohibits growth in response to DSB formation. To quantitate HSPCs number and functionality following exposure to Que and Eto we employed colony-forming assay. As can be seen in Figure 1d , 27 To test the consequences of Que treatment and subsequent DDR on HSPC maintenance we monitored cell number in cytokinedependent cultures for two weeks post treatment. Solvent treated cells amplified almost 70-fold within 15 days, by contrast, overnight exposure to Que (50 lM) blocked expansion during the first week post-treatment followed by a modest recovery (Fig. 1e) . Taken together, these data indicate that Que induces DNA damage and decreases survival of cycling primitive hematopoietic cells. MLL rearrangements are a hallmark of genomic aberrations induced by Eto exposure. Given the established role of Eto in the generation of MLL rearrangements on the one hand 29 and findings pointing to a similar capacity of Que on the other 9,10 we decided to assess MLL rearrangement frequencies in CD34 1 HSPCs recovered from Eto, Que or their concomitant treatment. As expected, we found increased incidence of MLL structural rearrangements (manifested as complete or partial loss of the 3' MLL locus) in HSPCs exposed to Eto. Que treatment also resulted in the complete or partial loss of 3'MLL segment to a similar extent (Table 1) . Most interestingly, we found an additive increase in MLL structural rearrangements in HSPCs recovered from the combined Eto and Que treatments (Fig. 1f) . Importantly, no change in the proportion of gH2AX positive cells was detected upon concomitant addition of Que and Eto (Supporting Information  Fig. 3 ). In contrast to the structural rearrangements, Que, Eto or their combination did not significantly affect numerical changes, such as loss or duplication of the entire MLL gene.
Collectively, these results uncovered that Que flavonoid can reach fetal HSPC, induce DNA damage in their cycling fraction and could contribute to MLL rearrangements via TopoII-independent activity.
Que suppresses multiple DNA double strand repair pathways Chromosomal aberrations stem in large from the failure of DNA repair machineries to accurately rejoin DSBs. However, the impact of Que on DNA repair activities implicated in MLL rearrangement remains unexplored.
Since gH2AX damage formation via Eto and Que was epistatic, i.e. TopoII-dependent, however, Eto-and Que-induced MLL-rearrangements were additive, we aimed to decipher a possible role of Que in the repair of breaks in the MLL breakpoint cluster region (bcr). To that end we measured the frequency of DNA recombination (HR) provoked by MLL breakage using a chromosomally integrated reporter system in K562 leukemia cells (Fig. 2a) . This reporter system employs a 399-bp MLLbcr fragment inserted as a spacer into an established enhanced green fluorescent protein positive (EGFP)-based recombination cassette. Genotoxicities and replication stress were shown to enhance MLLbcr-triggered breakage and subsequent DNA recombination via homology driven repair leading to an increased proportion of EGFP 1 cells. 20, 23, 30 As expected, Eto, a known TopoII poison and strong inducer of MLL cleavage augmented reporter activity over 50-fold. On the other hand, Que did not alter the frequencies of recombination compared with the solvent control. Surprisingly, the combination of Que and Eto resulted in complete suppression of Eto-induced DNA recombination at the MLLbcr (Fig. 2b) . Since MLLbcr spacer breakage precedes EGFP repair reconstitution we analyzed MLLbcr fragment integrity by genomic PCR upon treatment with Que. As can be seen in Figure 2c , Que disrupted MLLbcr integrity to a similar extent as Eto. To test whether the observed suppression of homology driven repair of Que-and Eto-induced MLL breaks by Que reflects suppression of DNA repair we employed a TopoII-and MLLbcr-independent strategy to generate a DSB in the reporter cassette. To that end we initiated DNA repair by I-SceI endonuclease-mediated cleavage at its recognition site in the HR-EGFP acceptor sequence in the HR-EGFP/3EGFP-hygro reporter with replacement of the MLLbcr spacer by a hygromycin resistance cassette (Fig. 2a) . I-SceI stimulated DNA recombination 10-fold, but addition of Que significantly attenuated this effect (Fig. 2d) . Que treatment did neither interfere with nucleofection efficiency, EGFP expression nor I-SceI DNA restriction capacity (Supporting Information Fig. 4 and data not shown). Que-related bioflavonoid Genistein also exhibited suppression of Eto induced DNA recombination at the MLLbcr (Supporting Information Fig. 5 ). These results reveal that Que and Genistein suppress homology driven repair activity downstream of DSB generation.
Non-homologous End Joining (NHEJ) is a major DSB repair pathway that is critically implicated in the maintenance of genome integrity and active in all stages of cell cycle. To test potential effects of Que on NHEJ we employed a different reporter in which EGFP expression is dependent on the rejoining of two I-SceI recognition sites 31 ( Fig. 2e) . Introduction of ISceI endonuclease expression plasmid together with the NHEJ reporter activated end joining in both leukemia (K562) and normal CD341 HSPCs derived from cord blood. Treatment of both cell types with Que resulted in NHEJ suppression as scored by low EGFP1 cell frequency (Figs. 2f and 2g) . Collectively, these experiments reveal the ability of Que to interfere with both NHEJ and HR DNA repair pathways in normal and malignant hematopoietic cells.
Que interferes with DNA repair activity via inhibition of PI3K/AKT pathway
In addition to its TopoII inhibitory capacity, Que was shown to inhibit PI3K by fitting into the ATP binding site of the enzyme. 32 Central DNA damage repair regulators, including DNA-PK and ATM, share sequence homology in their kinase domain with PI3K, thus making them potential additional targets for Que inhibition. Thus, we decided to use a pharmacological approach to examine a potential role of PI3K/ AKT/mTOR, DNA-PK and ATM signalling cascades in the inhibition of NHEJ and HR inhibition by Que.
Activation of ATM kinases is a key event in the induction of cell cycle arrest and promoting DNA repair upon DSB induction. To examine whether Que affects ATM activation we analysed Ser1981 autophosphorylation on ATM. We observed ATM activation following two hours of treatment with Que to the levels comparable to irradiation with 10 Gy (Fig. 3a) . ATM activation correlated with a large increase in the proportion of gH2AX positive cells confirming DSB accrual (Fig. 3b) . Moreover, Que stimulated activation of the ATM target Chk2. Therefore, Que activated the ATM-Chk2 axis most likely due to DNA damage induction. DNA-PK activation by DSB is essential for the classical NHEJ repair. Because we observed NHEJ inhibition by Que in our reporter assays we hypothesised that this compound might inhibit PI3K-related DNA-PK catalytic subunit (DNA-PKcs) kinase activity. To test this hypothesis we analyzed Ser2056 autophosphorylation as a marker for DNA-PK activity in leukemia cells exposed to Que or IR (Fig. 3a) . DNA damage produced by Que did not trigger Ser2056 autophosphorylation that was efficiently triggered by IR. The absence of DNA-PK activation upon DSB induction by Que can suggest either activation failure or inhibition of the DNA-PK kinase activity. In order to distinguish between these two possibilities we pre-incubated K562 cells with Que and then irradiated them. In this experimental setup we observed robust DNA-PKcs autophosphorylation on Ser2056 exceeding that of IR alone suggesting that Que does not inhibit DNA-PK kinase. Of note, PI3K inhibitor Ly294002, which is structurally related to Que, reduced IR-induced DNA-PK activation, in accordance with pervious findings, 33 but not IR-induced ATM activation.
Treatment of K562 leukemia cells with Que led to the attenuation of Akt activation, but not of mTOR as judged by the decrease in phosphorylated Akt (Ser473) and no detectable change in phosphorylated 4E-BP1 (Thr37/46) pointing to the specific interference with PI3K (Fig. 3c) . Of note, Ly294002, inhibited both Akt and 4E-BP1 phosphorylation in agreement with previous reports. 34 Quercitrin, a glycosylated form of Que, and Eto did not inhibit Akt and 4E-BP1phosphorylation (Fig. 3c) .
These results indicate that in K562 leukemia cells Que differentially alters the activity of numerous PI3K related enzymes, namely, it induces ATM activation and ATMmediated phosphorylation of Chk2, very likely via DNA damage accumulation, does not interfere with DNA-PK and blocks basal and induced Akt activity. To test whether the decrease in NHEJ and HR activities by Que can be attributed to its ability to block PI3K, we performed DNA repair reporter studies in the presence of Ly294002. Indeed, we found that Ly294002 blocked I-SceI induced HR and NHEJ DNA repair activity to the extent of Que itself (Figs. 3d and  3e) . Of note, both Que and Ly2904002 blocked DSB repair activity at PI3K inhibitory concentrations. Quercitrin did not affect NHEJ or HR DNA repair activity in agreement with the absence of PI3K inhibition. Application of DNA-PK and ATM specific inhibitors led to the expected downregulation of NHEJ and HR reporter activity respectively (Figs. 3d and 3e) .
These results highlight PI3K as the cellular target of Que accounting for its ability to interfere with DSB repair.
Que alters the abundance of DNA repair components in a PI3K-dependent manner PI3K/Akt signalling was recently implicated in the transcriptional regulation of a number of DNA repair genes mediating HR and NHEJ. [35] [36] [37] Given concomitant Akt activity suppression and DSB repair capacity decline in the presence of Que, we hypothesized that this bioflavonoid may impact the expression of some HR and NHEJ genes. To validate this hypothesis we measured expression of selected DSB repair transcripts in K562 cells exposed to Que and Ly294002 for 24 and 48 hrs (Fig. 4a) . We found a four-fold decrease in DNA-PKcs and a twofold decrease in KU80 transcripts in cells treated with Que or Ly294002. Furthermore, a twofold Figure 3 . Pharmacological dissection of the Que activity associated with DSB repair inhibition. (a) K562 cells were treated with the indicated compounds (50 lM for all inhibitors) for 1 hrs, and then half of the cells were irradiated with 10 Gy. Protein lysates were prepared 30 min post-irradiation and the levels of P-DNA-PK, P-ATM, P-Chk2, P-Chk1 were analyzed by Western immunoblotting. b-actin detection was used to assure equal loading and blotting of the samples. (b) K562 cells were exposed to Que (50 lM), Quercitrin (Qui, 50 lM), Ly294002 (Ly, 50 lM) for the indicated time followed by fixation and flow cytometry based analysis of the gH2AX positive cells. (c) K562 cells were incubated with the indicated compounds for 4 hrs at the following concentrations: Que (10 and 50 lM), Qui (50 lM), Ly (10 and 50 lM), Etoposide (Eto, 3 lM). Phorbol 12-myristate 13-acetate (PMA) exposure (10 ng/ml for 30 min) was used as a positive control for PI3K activation. Then cells were lysed and the levels of P-AKT, total AKT, P-4EBP1, total 4EBP1 and b-actin were detected by immunoblotting. Representative immunoblot image of three independent experiments is shown. (d) K562 cells were nucleofected with plasmids for pimEJ5GFP reporter and I-SceI endonuclease expression plasmid and cultured in the presence of DMSO, Que (10 and 50 lM), Qui (50 lM), Ly (10 and 50 lM) and DNA-PK inhibitor (DNA-PKi (Nu7441, 50 lM)). One day post-nucleofection, the number of viable EGFP1 cells was analyzed by flow cytometry and presented as fraction of DMSO treated sample, n 5 3. ***Indicates p < 0.0001. (e) K562 cells with chromosomally integrated HR-EGFP/3EGFP substrate were infected with I-SceI lentivirus and treated with the inhibitors as detailed in (d), including ATM inhibitor (ATMi (Ku55933, 50 lM) . The proportion of EGFP1 cells was measured by flow cytometry three days later, n 5 3. ***p < 0.0001. reduction in KU70 and ATM transcripts were documented in cells treated with Que. Additional NHEJ-(MRE11A, SIRT1) and HR-(BRCA1, BRCA2, RAD51 and FANCD2) related factors did not undergo changes at the mRNA level in the cells after 24 hrs of Que exposure (Fig. 4a, left panel) . Strikingly, prolonged incubation with Que and Ly294002 led to the downregulation of several HR factors (e.g. BRCA1, RAD51 and FANCD2) and more pronounced decrease in DNA-PKcs (Fig. 4a, right panel) . To further support above transcriptional changes, we analyzed protein levels of ATM, KU70 and RAD51 repair factors in K562 cells exposed to Que or Ly294002 (Fig. 4b) . Indeed, we found lower protein levels for all three factors upon Que or Ly294002 treatment. Collectively, these results identify PI3K/AKT axis inhibition with downstream transcriptional repression of a set of DSB repair genes as plausible mechanism that accounts for the decrease in DNA repair capacity by Que.
Discussion
There is a considerable amount of evidence indicating the ability of bioflavonoids to impact the viability of various cell types, as well as, to induce DSBs and promote MLL gene rearrangements. 9, 10 The latter are etiologically linked to infant leukemia. 7 In this study we provided three novel lines of evidence supporting corresponding mutagenic potential of Que: (i) its transfer via tissue-engineered PB, (ii) suppression of the two major DSB repair pathways implicated in MLL locus stability: NHEJ and HR and (iii) transcriptional downregulation of the key DNA repair factors by Que.
Some bioflavonoids, including Que, can be detected in the fetal tissues, implying placental transfer. 38, 39 In this work, using the in vitro PB model and conditions closely resembling fetal and maternal blood circulations we provided several novel insights into the dynamics of Que transfer. Firstly, in our experimental setting we evaluated that 10% of the initial maternal Que concentration is transferred to the fetal compartment. Secondly, we noticed the significant difference between the decreased levels of Que in the maternal compartment and its relative increase in the fetal compartment. Since we demonstrated that there is no degradation of Que in CM in the presence of Asc, the missing amount of Que must have been absorbed by trophoblast or endothelial cells that 
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build up the PB. Subsequently, gradual release of the accumulated Que molecules can provide a plausible explanation for the increased serum concentrations of phytoestrogens detected in the fetal blood relative to the maternal blood. 39 Moreover, flavonoid accumulation at the fetal side combined with its long half-life (25 h) 40 might result in prolonged exposure periods of the developing fetus.
Leukemia-associated reciprocal translocations, involving MLL, arise from unfaithful DNA repair of DSBs within the MLLbcr and on the partner chromosomes. 6, 29, 41 Here we confirmed previous findings indicating that Que is able to induce significant DNA damage as manifested by gH2AX positivity analysis, newly revealing it in human HSPCs with a dependency on cell proliferation. Surprisingly, quiescent HSPCs were resistant to DNA damage induction by Que.
Induction of DNA damage in cells by Que has been attributed to TopoII inhibition. 3 It is well established that HSPCs shortly after purification are quiescent. 28 In this state the level of TopoII alpha, the target of Que, 3 is considerably lower than in proliferating cells. 29 These factors might account for the relative resistance of quiescent HSPCs to DNA damage induction by Que. Importantly, our results also point to a causal relationship between the induction of DNA damage by Que and HSPCs survival. Indeed, fetal HSPCs are highly proliferative and thus Que can pose significant genotoxic injury upon these cells by exacerbating replication stress. 42 Interference with both NHEJ and HR by Que, as revealed in our work, represents a novel biological activity of this bioflavonoid. Inhibition of DSB repair pathways was evident irrespective of the manner by which DSBs were introduced, Figure 5 . Schematic illustration for Que exerted pro-mutagenic activities. Quercetin bioflavonoid as part of the normal maternal diet or as food supplement penetrates the placental barrier and reaches cycling fetal HSPC. Prolonged exposure to the compound leads to the accumulation of DSBs via TopoII cleavage complex stabilization at many genomic sites including fragile MLLbcr. Concurrently, Que inhibits Akt activity regulating multiple DSB repair genes (e.g. DNA-PKcs, KU80, ATM, BRCA2, RAD51). Decline in the repair factors availability will lead gradually to NHEJ and HR deficit. Based on our results, we suggest that increased DSBs load and persistence, as well as possible reliance on the error prone alternative end joining pathways, can lead to elevated rates of chromosomal aberrations at loci including MLL. namely by stabilizing TopoII cleavage complex or by I-SceI endonuclease. When monitoring breakage within the MLLbcr hotspot, 43 we observed that both Eto and Que cause breakage within the MLLbcr after 1 h exposure. However, only cells exposed to Eto showed augmentation of the recombination activity, whereas Que alone or their combined treatment failed to do so. The total amount of DNA damage as estimated by gH2AX quantitation revealed that Que did not inhibit DSB generation by Eto. Altogether, these data imply that Que exerts additional TopoII-independent effects on DSB repair, which may exacerbate Que-induced DNA damage formation in the MLLbcr. Most importantly, HSPCs exposed to Que and allowed to recover carried elevated numbers of deletions adjacent to the MLLbcr reaching frequencies induced by Eto as revealed by FISH analysis of the endogenous locus and in agreement with previous reports. 10, 12 Supporting a TopoII-independent mode-of-action of Que, our study documented an additive effect of Que and Eto co-exposure on MLL gene aberrations in HSPCs. We argue that mutagenic consequences of DSB repair inhibition by Que in addition to its inhibitory effect on Topo II can contribute to this strikingly elevated frequency of MLL rearrangements, which has physiological implications.
Our DNA repair functional studies using NHEJ-and HRspecific reporters implicated inhibition of PI3K/Akt signalling by Que to be responsible for the decline in the DNA repair capacity. Downregulation of DNA-PKcs and KU80 transcripts upon inhibition of PI3K/Akt signalling by Que can provide a plausible explanation for the observed inhibition of NHEJ. In analogy to the effect of ATM-inhibitor on HR, Que can repress HR by ATM downregulation, even though Queinduced DNA damage accumulation caused transient activation of ATM. Concomitantly, Que-induced repression of additional HR genes (e.g. BRCA2 and RAD51) can further inhibit HR activity in the treated cells. Importantly, Ly294002 inhibited mTOR, DNA-PK and PI3K activity, whereas Que affected directly only the latter. Thus, Que decreases steady state levels of NHEJ and HR related factors via affecting the PI3K-Akt axis (Fig. 5) . We can largely exclude chromatinmediated effects, as we observed DSB inhibition using both intra-and extrachromosomal reporter constructs.
Additional natural food constituents such as resveratrol, curcumin, caffeine as well as vegetarian-diet associated mycotoxins (e.g. alternariol) modulate DSB repair pathways and cell cycle checkpoints in human cancer cell lines and provide measurable sensitization to DSB inducers. [44] [45] [46] [47] This radiationand chemosensitizing effect can be potentially explored therapeutically. However, inhibition of NHEJ and HR pathways in normal hematopoietic cells as shown in this study with elevation in the frequency of leukemia causing gene rearrangements can impede the therapeutic utility of these chemicals. As human diet is very complex and contains numerous compounds with modulatory effects on the DDR pathway their combined and successive effect on the genome integrity of both normal and malignant cells should be evaluated. Transient exposures to Que as part of the normal nutrition may not be sufficient to fully exert its mutagenic potential. However, habitual intake of dietary supplements that contain up to 500 mg of Que can result in plasma concentration of 10 lM of this bioflavonoid. 48 If one considers that manufacturers of food supplements recommend a daily use of up to 1,200 mg/day, combined with its long half-life (25 hrs 40 ), accumulation and recirculation on the fetal side of the placenta (this study and Refs. 38,39,49, and 50) and a 9-month long "window of exposure" in the course of human pregnancy, it is possible to reach concentrations in the range of those applied in this study (50 lM) that produced mutagenic and genotoxic effects.
Although much work is still needed to define the exact mechanisms by which Que interacts with the DNA repair machinery in the context of fetal and maternal tissues in vivo, according to our current findings, high concentrations of Que would adversely affect genome integrity of the developing hematopoietic cells.
